BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 8631301)

  • 1. Kinase-negative mutants of JAK1 can sustain interferon-gamma-inducible gene expression but not an antiviral state.
    Briscoe J; Rogers NC; Witthuhn BA; Watling D; Harpur AG; Wilks AF; Stark GR; Ihle JN; Kerr IM
    EMBO J; 1996 Feb; 15(4):799-809. PubMed ID: 8631301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A JAK1/JAK2 chimera can sustain alpha and gamma interferon responses.
    Kohlhuber F; Rogers NC; Watling D; Feng J; Guschin D; Briscoe J; Witthuhn BA; Kotenko SV; Pestka S; Stark GR; Ihle JN; Kerr IM
    Mol Cell Biol; 1997 Feb; 17(2):695-706. PubMed ID: 9001223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential role of Janus family kinases (JAKs) in interferon-gamma-induced lung epithelial ICAM-1 expression: involving protein interactions between JAKs, phospholipase Cgamma, c-Src, and STAT1.
    Chang YJ; Holtzman MJ; Chen CC
    Mol Pharmacol; 2004 Mar; 65(3):589-98. PubMed ID: 14978237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycobacterium avium infection of mouse macrophages inhibits IFN-gamma Janus kinase-STAT signaling and gene induction by down-regulation of the IFN-gamma receptor.
    Hussain S; Zwilling BS; Lafuse WP
    J Immunol; 1999 Aug; 163(4):2041-8. PubMed ID: 10438942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
    Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C
    Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Jak kinases differentially associate with the alpha and beta (accessory factor) chains of the interferon gamma receptor to form a functional receptor unit capable of activating STAT transcription factors.
    Sakatsume M; Igarashi K; Winestock KD; Garotta G; Larner AC; Finbloom DS
    J Biol Chem; 1995 Jul; 270(29):17528-34. PubMed ID: 7615558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The TATA-containing core promoter of the type II collagen gene (COL2A1) is the target of interferon-gamma-mediated inhibition in human chondrocytes: requirement for Stat1 alpha, Jak1 and Jak2.
    Osaki M; Tan L; Choy BK; Yoshida Y; Cheah KS; Auron PE; Goldring MB
    Biochem J; 2003 Jan; 369(Pt 1):103-15. PubMed ID: 12223098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein tyrosine kinase Pyk2 mediates the Jak-dependent activation of MAPK and Stat1 in IFN-gamma, but not IFN-alpha, signaling.
    Takaoka A; Tanaka N; Mitani Y; Miyazaki T; Fujii H; Sato M; Kovarik P; Decker T; Schlessinger J; Taniguchi T
    EMBO J; 1999 May; 18(9):2480-8. PubMed ID: 10228162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
    Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
    Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Jak-STAT pathway stimulated by interferon gamma.
    Horvath CM
    Sci STKE; 2004 Nov; 2004(260):tr8. PubMed ID: 15561980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential tyrosine phosphorylation of JAK1, JAK2, and STAT1 by growth hormone and interferon-gamma in IM-9 cells.
    Silva CM; Lu H; Weber MJ; Thorner MO
    J Biol Chem; 1994 Nov; 269(44):27532-9. PubMed ID: 7525556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of interferon-gamma inducibility of TAP1 and LMP2 in a renal cell carcinoma cell line.
    Dovhey SE; Ghosh NS; Wright KL
    Cancer Res; 2000 Oct; 60(20):5789-96. PubMed ID: 11059775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus core protein differently regulates the JAK-STAT signaling pathway under interleukin-6 and interferon-gamma stimuli.
    Hosui A; Ohkawa K; Ishida H; Sato A; Nakanishi F; Ueda K; Takehara T; Kasahara A; Sasaki Y; Hori M; Hayashi N
    J Biol Chem; 2003 Aug; 278(31):28562-71. PubMed ID: 12764155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-beta attenuates the class II transactivator and reveals an accessory pathway of IFN-gamma action.
    Nandan D; Reiner NE
    J Immunol; 1997 Feb; 158(3):1095-101. PubMed ID: 9013947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leishmania inhibits STAT1-mediated IFN-gamma signaling in macrophages: increased tyrosine phosphorylation of dominant negative STAT1beta by Leishmania mexicana.
    Bhardwaj N; Rosas LE; Lafuse WP; Satoskar AR
    Int J Parasitol; 2005 Jan; 35(1):75-82. PubMed ID: 15619518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-beta suppression of IFN-gamma-induced class II MHC gene expression does not involve inhibition of phosphorylation of JAK1, JAK2, or signal transducers and activators of transcription, or modification of IFN-gamma enhanced factor X expression.
    Panek RB; Lee YJ; Benveniste EN
    J Immunol; 1995 Jan; 154(2):610-9. PubMed ID: 7814871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A selective defect of IFN-gamma- but not of IFN-alpha-induced JAK/STAT pathway in a subset of U937 clones prevents the antiretroviral effect of IFN-gamma against HIV-1.
    Bovolenta C; Lorini AL; Mantelli B; Camorali L; Novelli F; Biswas P; Poli G
    J Immunol; 1999 Jan; 162(1):323-30. PubMed ID: 9886402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist.
    Best SM; Morris KL; Shannon JG; Robertson SJ; Mitzel DN; Park GS; Boer E; Wolfinbarger JB; Bloom ME
    J Virol; 2005 Oct; 79(20):12828-39. PubMed ID: 16188985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unexpected transcriptional signals in normal and mitotically defective cells mediated through cytokine and growth factor receptors.
    Samanta A; Qian X; Greene MI
    DNA Cell Biol; 1995 Nov; 14(11):921-30. PubMed ID: 7576178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and -gamma signal transduction.
    Müller M; Briscoe J; Laxton C; Guschin D; Ziemiecki A; Silvennoinen O; Harpur AG; Barbieri G; Witthuhn BA; Schindler C
    Nature; 1993 Nov; 366(6451):129-35. PubMed ID: 8232552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.